[Renal function during water-salt depletion. Effects of alpha-blocking treatment with prazosin].
Agnoli
G C
GC
Cacciari
M
M
Garutti
C
C
Lenzi
P
P
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D005919:Glomerular Filtration Rate / Q000187:drug effects; D005947:Glucose / Q000009:adverse effects; D006801:Humans; D017136:Ion Transport / Q000187:drug effects; D007668:Kidney / Q000294:innervation / Q000503:physiopathology*; D007686:Kidney Tubules, Distal / Q000187:drug effects / Q000503:physiopathology; D009318:Natriuresis / Q000187:drug effects; D011141:Polyuria / Q000139:chemically induced / Q000150:complications; D011224:Prazosin / Q000494:pharmacology / Q000627:therapeutic use*; D011942:Receptors, Adrenergic, alpha / Q000502:physiology; D012079:Renal Circulation / Q000187:drug effects; D012964:Sodium / Q000378:metabolism; D014655:Vascular Resistance / Q000187:drug effects; D014883:Water-Electrolyte Imbalance / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology
D000317:Adrenergic alpha-Antagonists; D011942:Receptors, Adrenergic, alpha; D012964:Sodium; D005947:Glucose; D011224:Prazosin